FindTrial
Sign In

Management of pain due to Intra Uterine Copper Device (Copper T) insertion with Drotaverine and Mefenamic acid

EFFICACY OF DROTAVERINE AND MEFENAMIC ACID (DROTIN-M)IN THE TREATMENT OF PAIN FOLLOWING IUCD INSERTION

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2014/05/004580
Enrollment
36
Registered
2014-05-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: drotaverine (80 mg) with mefenamic acid (250 mg): fixed-dose oral tablet containing drotaverine (80 mg) with mefenamic acid (250 mg). received the drug half an hour before intrauterine

Sponsors

All India Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: healthy females Seeking intrauterine device as contraception

Exclusion criteria

Exclusion criteria: (1) Pregnancy; (2) Having a known sensitivity to nonsteroidal anti-inflammatory drugs, lignocaine; (3) Having peptic ulcer disease, inflammatory bowel disease, porphyrias, genital infections, undiagnosed vaginal bleeding cervical stenosis, serious cardiac disease; (4) Being unable or unwilling to provide informed consent; And (5) Having history of cervical surgery.

Design outcomes

Primary

MeasureTime frame
PAIN SCORES(VAS)Timepoint: 4 hours and 5 days—

Secondary

MeasureTime frame
Adverse effects of drugsTimepoint: 0,15 min,30 min—

Countries

India

Contacts

Public ContactJai B Sharma

All India Institute of Medical Science

jbsharma2000@gmail.com9868397309

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026